‘no-deal’
Hancock queried over UK's access to medicine in 'no deal' Brexit
Concerns have been raised over the government’s contingency plans for whether the UK can ensure a suitable supply of medicines in the event of a ‘no deal’ Brexit. Read more
Industry responds to the government’s technical notices published in case of a ‘no-deal’ Brexit
Following a speech from the secretary of state, Dominic Raab, on the steps that government as well as business and the public sector should be taking in case of a ‘no-deal’ scenario for Brexit, we take a look at some of the responses from industry… Read more
ABPI responds to NHS England boss’ comments on Brexit preparations
The Association of the British Pharmaceutical Industry has issued a response to comments made by Simon Stevens — chief executive of NHS England — during his interview on the Andrew Marr show earlier this month. Read more
EMA relocation voting commences and UK pharma prepares for ‘no-deal’ Brexit
Today (Monday 20 November) is the day that will see the first vote on the new location of the European Medicines Agency (EMA) be made by European Union (EU) ministers. Read more
